Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$324M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$281M |
| 4 |
DuPont de Nemours
DD
|
+$278M |
| 5 |
HCC
HCC INSURANCES HOLDINGS INC
HCC
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$830M |
| 2 |
Johnson & Johnson
JNJ
|
+$281M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$205M |
| 4 |
Bausch Health
BHC
|
+$183M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.85% |
| 2 | Technology | 3.93% |
| 3 | Financials | 3.3% |
| 4 | Energy | 3.26% |
| 5 | Communication Services | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
1701
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.18M | ﹤0.01% |
20,400
+4,200
| +26% | +$766K |
|
1702
NGL Energy Partners
NGL
$2.11B
| $3.18M | ﹤0.01% |
167,376
-17,241
| -9% | -$439K |
|
|
CSC
1703
CALL
DELISTED
Computer Sciences
CSC
| $3.18M | ﹤0.01% |
123,633
+42,714
| +53% | +$1.15M |
|
1704
PUT
Murphy Oil
MUR
$4.78B
| $3.17M | ﹤0.01% |
132,300
+3,800
| +3% | +$121K |
|
1705
PUT
Akamai
AKAM
$15.9B
| $3.17M | ﹤0.01% |
46,000
-19,400
| -30% | -$1.4M |
|
1706
CALL
Trinity Industries
TRN
$2.38B
| $3.16M | ﹤0.01% |
199,322
+106,815
| +115% | +$2.03M |
|
1707
PUT
Perrigo
PRGO
$1.78B
| $3.16M | ﹤0.01% |
20,100
-7,500
| -27% | -$1.38M |
|
1708
Meritage Homes
MTH
$4.86B
| $3.15M | ﹤0.01% |
175,302
+113,210
| +182% | +$2.43M |
|
1709
CALL
CNX Resources
CNX
$5.2B
| $3.15M | ﹤0.01% |
420,120
+188,760
| +82% | +$2.34M |
|
|
FLXN
1710
CALL
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.15M | ﹤0.01% |
+225,000
| New | +$5.28M |
|
1711
Realty Income
O
$59.1B
| $3.14M | ﹤0.01% |
69,044
-100,445
| -59% | -$4.53M |
|
1712
CALL
TC Energy
TRP
$65.9B
| $3.14M | ﹤0.01% |
101,400
+30,100
| +42% | +$1.08M |
|
1713
PUT
Coca-Cola Europacific Partners
CCEP
$47.9B
| $3.14M | ﹤0.01% |
65,400
+53,200
| +436% | +$2.59M |
|
1714
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $3.14M | ﹤0.01% |
57,988
-27,576
| -32% | -$1.5M |
|
|
ASRT
1715
CALL
DELISTED
Assertio
ASRT
| $3.13M | ﹤0.01% |
+2,900
| New | +$4.95M |
|
|
DNB
1716
DELISTED
Dun & Bradstreet
DNB
| $3.13M | ﹤0.01% |
29,827
+12,083
| +68% | +$1.38M |
|
1717
Alnylam Pharmaceuticals
ALNY
$29.3B
| $3.13M | ﹤0.01% |
39,133
+26,649
| +213% | +$2.96M |
|
1718
Packaging Corp of America
PKG
$22.8B
| $3.13M | ﹤0.01% |
52,164
+8,179
| +19% | +$546K |
|
|
WX
1719
CALL
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $3.13M | ﹤0.01% |
72,700
+49,000
| +207% | +$2.07M |
|
1720
Xylem
XYL
$28.1B
| $3.12M | ﹤0.01% |
97,433
+27,054
| +38% | +$910K |
|
1721
CALL
Neurocrine Biosciences
NBIX
$16.6B
| $3.11M | ﹤0.01% |
79,800
-113,200
| -59% | -$5.47M |
|
1722
Lattice Semiconductor
LSCC
$18.5B
| $3.11M | ﹤0.01% |
1,035,510
+718,406
| +227% | +$3.31M |
|
1723
Universal Display
OLED
$4.19B
| $3.11M | ﹤0.01% |
94,114
+63,066
| +203% | +$2.63M |
|
1724
Dick's Sporting Goods
DKS
$18.7B
| $3.1M | ﹤0.01% |
63,281
+37,646
| +147% | +$1.9M |
|
|
AERI
1725
DELISTED
Aerie Pharmaceuticals
AERI
| $3.1M | ﹤0.01% |
182,286
+173,553
| +1,987% | +$3.14M |
|
Similar funds
Barclays's Q3 2015 Portfolio in Review
As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.
- Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
- Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
- Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
- Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
- Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
- Barclays opened 382 new positions and closed 515 in Q3 2015.
- Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.
Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.